Metropolis Therapeutics’ lead RNA interference remedy may change into an alternative choice to blockbuster-selling anticoagulants. The corporate’s expertise for designing RNAi medicine and delivering them to tissues all through the physique has already led to partnerships with Bausch + Lomb in eye illnesses and Biogen in central nervous system issues.
The submit Metropolis Therapeutics’ Upsized IPO Raises $200M to Deliver RNAi Medicine Past the Liver appeared first on MedCity Information.
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!
